Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2018 19:06 ET | Source: LogicBio Therapeutics

LogicBio Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant...